Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation

Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Methods. In a matched study, we compared markers of repe...

Full description

Bibliographic Details
Main Authors: Vinzent Spetzler, MD, Nicolas Goldaracena, MD, Johann Moritz Kaths, MD, Max Marquez, MD, Markus Selzner, MD, Nazia Selzner, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2017-08-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684
_version_ 1811330968116527104
author Vinzent Spetzler, MD
Nicolas Goldaracena, MD
Johann Moritz Kaths, MD
Max Marquez, MD
Markus Selzner, MD
Nazia Selzner, MD, PhD
author_facet Vinzent Spetzler, MD
Nicolas Goldaracena, MD
Johann Moritz Kaths, MD
Max Marquez, MD
Markus Selzner, MD
Nazia Selzner, MD, PhD
author_sort Vinzent Spetzler, MD
collection DOAJ
description Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Methods. In a matched study, we compared markers of reperfusion injury (alanine aminotransferase/aspartate aminotransferase) and transplantation outcome (complication rates, liver function, and survival) between recipient groups with “normal” versus “increased” preoperative bilirubin values. Groups were matched for donor and recipient age, liver disease, year of transplantation, and recipient’s preoperative condition (modified model for end-stage liver disease score excluding bilirubin). Results. The postoperative transaminase peak was significantly higher when comparing the “normal” to the “increased” bilirubin group (maximum aspartate aminotransferase “normal” 2013 [325-13 210] U/L vs “increased” 1360 [221-15 460] U/L, P = 0.006; maximum alanine aminotransferase “normal” 1151 [82-6595] U/L vs “increased” 820 [66-5382] U/L, P = 0.01). Grafts in the “increased” bilirubin group had faster recovery of graft function with faster decrease in international normalized ratio at days 3 and 7 posttransplantation in the “increased” vs “normal” bilirubin group. Although long-term functional parameters (international normalized ratio and bilirubin posttransplantation) as well as surgical and biliary complication rates were similar in both groups, 1-year survival rates were significantly higher in the group with increased preoperative bilirubin (graft survival, “normal” 86% vs “increased” 97%; P = 0.006). Conclusions. Increased bilirubin levels of liver graft recipients before transplantation are associated with reduced reperfusion injury and improved survival after transplantation.
first_indexed 2024-04-13T16:10:46Z
format Article
id doaj.art-57729e6b681149368d2a150bb8e7f7d3
institution Directory Open Access Journal
issn 2373-8731
language English
last_indexed 2024-04-13T16:10:46Z
publishDate 2017-08-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj.art-57729e6b681149368d2a150bb8e7f7d32022-12-22T02:40:14ZengWolters KluwerTransplantation Direct2373-87312017-08-0138e18710.1097/TXD.0000000000000684201708000-0009Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver TransplantationVinzent Spetzler, MD0Nicolas Goldaracena, MD1Johann Moritz Kaths, MD2Max Marquez, MD3Markus Selzner, MD4Nazia Selzner, MD, PhD51 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.1 Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.2 Department of Medicine, Multi Organ Transplant Program, Toronto General Hospital, University of Toronto, Toronto, Canada.Background. The cytoprotective effects of hemeoxygenase-1 and its product biliverdin/bilirubin are widely acknowledged in experimental transplant medicine. However, its potentially beneficial effect during organ reperfusion is not established. Methods. In a matched study, we compared markers of reperfusion injury (alanine aminotransferase/aspartate aminotransferase) and transplantation outcome (complication rates, liver function, and survival) between recipient groups with “normal” versus “increased” preoperative bilirubin values. Groups were matched for donor and recipient age, liver disease, year of transplantation, and recipient’s preoperative condition (modified model for end-stage liver disease score excluding bilirubin). Results. The postoperative transaminase peak was significantly higher when comparing the “normal” to the “increased” bilirubin group (maximum aspartate aminotransferase “normal” 2013 [325-13 210] U/L vs “increased” 1360 [221-15 460] U/L, P = 0.006; maximum alanine aminotransferase “normal” 1151 [82-6595] U/L vs “increased” 820 [66-5382] U/L, P = 0.01). Grafts in the “increased” bilirubin group had faster recovery of graft function with faster decrease in international normalized ratio at days 3 and 7 posttransplantation in the “increased” vs “normal” bilirubin group. Although long-term functional parameters (international normalized ratio and bilirubin posttransplantation) as well as surgical and biliary complication rates were similar in both groups, 1-year survival rates were significantly higher in the group with increased preoperative bilirubin (graft survival, “normal” 86% vs “increased” 97%; P = 0.006). Conclusions. Increased bilirubin levels of liver graft recipients before transplantation are associated with reduced reperfusion injury and improved survival after transplantation.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684
spellingShingle Vinzent Spetzler, MD
Nicolas Goldaracena, MD
Johann Moritz Kaths, MD
Max Marquez, MD
Markus Selzner, MD
Nazia Selzner, MD, PhD
Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
Transplantation Direct
title Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
title_full Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
title_fullStr Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
title_full_unstemmed Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
title_short Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation
title_sort elevated preoperative serum bilirubin improves reperfusion injury and survival postliver transplantation
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000684
work_keys_str_mv AT vinzentspetzlermd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation
AT nicolasgoldaracenamd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation
AT johannmoritzkathsmd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation
AT maxmarquezmd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation
AT markusselznermd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation
AT naziaselznermdphd elevatedpreoperativeserumbilirubinimprovesreperfusioninjuryandsurvivalpostlivertransplantation